Headache After Coil Embolization for Unruptured Intracranial Aneurysms (Non-Stent-Assisted Versus Stent-Assisted): A Prospective Comparative Cohort Study. [PDF]
Eur J NeurolAmong patients treated with coil embolization for UIAs, patients treated with SACE were more likely to experience headache after coil embolization than those treated with NSCE were. However, changes in headache intensity over time were not significantly different between the groups.
Ban SP +11 more
europepmc +2 more sources
PLoS ONE, 2022 ObjectiveTo evaluate the efficacy and safety of cilostazol, pentoxifylline, beraprost for intermittent claudication due to lower extremity arterial occlusive disease.MethodsRandomized controlled clinical trials were identified from PubMed, Scopus, EMbase,
Xinyu Liang +3 more
doaj +2 more sources
Crystals, 2020 The cocrystal formation of pharmaceuticals can improve the various physical properties of drugs, such as solubility, without the need for chemical modification of the drug substances.
Maho Urano +6 more
doaj +1 more source
Cardioprotective Effect of Cilostazol on Ischemia-Reperfusion Injury Model
Brazilian Journal of Cardiovascular Surgery, 2021 Introduction: To clarify the potential protective role of cilostazol on rat myocardial cells with ischemia-reperfusion injury (IRI) models. Methods: The study was conducted with three groups of 10 Wistar rats (control group, rats without any coronary ...
Mazlum Sahin +2 more
doaj +1 more source
PLoS ONE, 2022 PurposeDrug-eluting stents (DESs) play an important role in endovascular therapy (EVT) for femoropopliteal (FP) lesions. Cilostazol improves patency after bare-metal nitinol stent (BNS) implantation for femoropopliteal lesions.
Takashi Miura +10 more
doaj +1 more source
Cilostazol inhibits accumulation of triglyceride in aorta and platelet aggregation in cholesterol-fed rabbits. [PDF]
PLoS ONE, 2012 Cilostazol is clinically used for the treatment of ischemic symptoms in patients with chronic peripheral arterial obstruction and for the secondary prevention of brain infarction.
Hideki Ito +7 more
doaj +1 more source
Efficacy of antiplatelet therapy in secondary prevention following lacunar stroke:Pooled analysis of randomized trials [PDF]
, 2015 Background and Purpose: Lacunar stroke accounts for ≈25% of ischemic stroke, but optimal antiplatelet regimen to prevent stroke recurrence remains unclear.
Benavente, Oscar R. +5 more
core +1 more source
Atomic-level characterization and cilostazol affinity of poly(lactic acid) nanoparticles conjugated with differentially charged hydrophilic molecules [PDF]
, 2018 Indexación: Scopus.M.F.M. acknowledges support from CONICYT-PFCHA/Doctorado Nacional/2014-21140225. M.M.M. thanks the FONCyT PICT-2015-2191, CONICET PIP 11220110100992, Secyt, Universidad Nacional de Cordoba. C.V.
Ludueña, M. +4 more
core +2 more sources
Is there a role for oral triple therapy in patients with acute coronary syndromes without atrial fibrillation? [PDF]
, 2018 © 2018 Bentham Science PublishersBACKGROUND: Acute coronary syndrome (ACS) patients, despite treatment with dual antiplatelet therapy (DAPT), have up to 10% risk of recurrent major adverse cardiac events (MACE) in the short term.
Akhtar, Zaki +3 more
core +2 more sources
Effect of cilostazol on arteriovenous fistula in hemodialysis patients
Nefrología (English Edition), 2021 Background: The maturation and patency of permanent vascular access are critical in patients requiring hemodialysis. Although numerus trials have been attempted to achieve permanently patent vascular access, little have been noticeable.
Jae Wan Jeon +8 more
doaj +3 more sources